FreeTrials & Tribulations A comparison of study designs for estimating overdiagnosis in cancer screening May 03, 2019Vol.45 No.18By Barry Kramer and Philip C. Prorok
Martine Roussel, Elaine Ostrander, Timothy Ley, Harmit Malik, Staffan Normark and Moshe Oren are among newly elected National Academy of Sciences members May 03, 2019Vol.45 No.18
Conversation with The Cancer Letter Hirsch: Syapse collaboration with Amgen will focus on real world evidence and hematologic malignancies May 03, 2019Vol.45 No.18By Matthew Bin Han Ong
House subcommittee bill gives NIH a $2 billion raise in FY2020—but budget caps must be raised May 03, 2019Vol.45 No.18By Claire Dietz and Matthew Bin Han Ong
Guest Editorial Getting beyond the immunotherapy divide: a call to action May 03, 2019Vol.45 No.18By John H. Stewart and Robert A. Winn
Collins: “Not every one of these investigations is going to reveal something bad, but some of them will” April 26, 2019Vol.45 No.17
Conversation with The Cancer Letter NIH’s Lauer: “We have contacted over 55 institutions” April 26, 2019Vol.45 No.17By Paul Goldberg
Conversation with The Cancer Letter Pisters: “Trust is broken when a grant reviewer decides that an idea should be better done elsewhere” April 26, 2019Vol.45 No.17By Paul Goldberg
MD Anderson researchers ousted as NIH and FBI target diversion of intellectual property April 26, 2019Vol.45 No.17By Paul Goldberg
